Listed

Alamar Biosciences, Inc.

ALMRNasdaqCIK 2104204TechnologyFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$29.4m, Q2 FY2026
Operating income−$13.5m, Q2 FY2026
Net income−$13.2m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m13.1Revenue, period not labelled, three months to 2025-03-31$13.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure16.2Revenue, period not labelled, three months to 2025-06-30$16.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure26.0Revenue, Q1 FY2026, three months to 2026-03-31$26.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure29.4Revenue, Q2 FY2026, three months to 2026-06-30$29.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Cost of revenue$m6.7Cost of revenue, period not labelled, three months to 2025-03-31$6.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure7.6Cost of revenue, period not labelled, three months to 2025-06-30$7.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure11.6Cost of revenue, Q1 FY2026, three months to 2026-03-31$11.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure11.7Cost of revenue, Q2 FY2026, three months to 2026-06-30$11.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Gross profit$m6.4Gross profit, period not labelled, three months to 2025-03-31$6.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure8.6Gross profit, period not labelled, three months to 2025-06-30$8.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure14.5Gross profit, Q1 FY2026, three months to 2026-03-31$14.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure17.7Gross profit, Q2 FY2026, three months to 2026-06-30$17.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Research and development$m8.3Research and development, period not labelled, three months to 2025-03-31$8.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure8.9Research and development, period not labelled, three months to 2025-06-30$8.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure13.0Research and development, Q1 FY2026, three months to 2026-03-31$13.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure13.8Research and development, Q2 FY2026, three months to 2026-06-30$13.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Selling, general and administrative$m6.6Selling, general and administrative, period not labelled, three months to 2025-03-31$6.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure7.6Selling, general and administrative, period not labelled, three months to 2025-06-30$7.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure13.8Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$13.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure17.4Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$17.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Operating income$m(8.6)Operating income, period not labelled, three months to 2025-03-31−$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure(7.9)Operating income, period not labelled, three months to 2025-06-30−$7.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure(12.3)Operating income, Q1 FY2026, three months to 2026-03-31−$12.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure(13.5)Operating income, Q2 FY2026, three months to 2026-06-30−$13.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Income tax$mnot reportednot reported0.5Income tax, Q1 FY2026, three months to 2026-03-31$464.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure(0.1)Income tax, Q2 FY2026, three months to 2026-06-30−$93.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Net income$m(7.7)Net income, period not labelled, three months to 2025-03-31−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure(7.0)Net income, period not labelled, three months to 2025-06-30−$7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure(21.3)Net income, Q1 FY2026, three months to 2026-03-31−$21.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure(13.2)Net income, Q2 FY2026, three months to 2026-06-30−$13.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Diluted EPS$ per share(0.68)Diluted EPS, period not labelled, three months to 2025-03-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure(0.62)Diluted EPS, period not labelled, three months to 2025-06-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure(1.74)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure(0.22)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Basic EPS$ per share(0.68)Basic EPS, period not labelled, three months to 2025-03-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure(0.62)Basic EPS, period not labelled, three months to 2025-06-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure(1.74)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure(0.22)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure

Balance sheet

Cash and equivalents$133.0m, Q2 FY2026
Shareholders' equity$312.9m, Q2 FY2026
Line itemUnitperiod not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30period not labelled2025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reportednot reportednot reported30.0Cash and equivalents, period not labelled, at 2025-12-31$30.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure64.6Cash and equivalents, Q1 FY2026, at 2026-03-31$64.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure133Cash and equivalents, Q2 FY2026, at 2026-06-30$133.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Current assets$mnot reportednot reportednot reported94.7Current assets, period not labelled, at 2025-12-31$94.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure141Current assets, Q1 FY2026, at 2026-03-31$141.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure331Current assets, Q2 FY2026, at 2026-06-30$331.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Total assets$mnot reportednot reportednot reported140Total assets, period not labelled, at 2025-12-31$140.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure186Total assets, Q1 FY2026, at 2026-03-31$186.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure391Total assets, Q2 FY2026, at 2026-06-30$391.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Current liabilities$mnot reportednot reportednot reported23.7Current liabilities, period not labelled, at 2025-12-31$23.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure24.0Current liabilities, Q1 FY2026, at 2026-03-31$24.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure28.0Current liabilities, Q2 FY2026, at 2026-06-30$28.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Total liabilities$mnot reportednot reportednot reported64.0Total liabilities, period not labelled, at 2025-12-31$64.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure130Total liabilities, Q1 FY2026, at 2026-03-31$129.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure78.1Total liabilities, Q2 FY2026, at 2026-06-30$78.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure
Shareholders' equity$m(133)Shareholders' equity, period not labelled, at 2024-12-31−$133.4m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure(140)Shareholders' equity, period not labelled, at 2025-03-31−$140.3m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure(147)Shareholders' equity, period not labelled, at 2025-06-30−$146.6m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure(159)Shareholders' equity, period not labelled, at 2025-12-31−$159.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure(178)Shareholders' equity, Q1 FY2026, at 2026-03-31−$178.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure313Shareholders' equity, Q2 FY2026, at 2026-06-30$312.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure

Cash flow

Operating cash flow−$11.3m, Q2 FY2026
Capital expenditure$3.6m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(13.1)Operating cash flow, period not labelled, three months to 2025-03-31−$13.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure(11.9)Operating cash flow, period not labelled, three months to 2025-06-30−$11.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343003. Derived: 6-month figure less the 3-month figure.Report this figure(20.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$20.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure(11.3)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$11.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343003. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.6Capital expenditure, period not labelled, three months to 2025-03-31$554.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure0.8Capital expenditure, period not labelled, three months to 2025-06-30$753.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343003. Derived: 6-month figure less the 3-month figure.Report this figure0.6Capital expenditure, Q1 FY2026, three months to 2026-03-31$600.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure3.6Capital expenditure, Q2 FY2026, three months to 2026-06-30$3.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343003. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)58.67m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares11.3Diluted shares (weighted), period not labelled, three months to 2025-03-3111,258,870 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure11.4Diluted shares (weighted), period not labelled, three months to 2025-06-3011,409,556 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure12.3Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3112,259,811 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure58.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3058,665,055 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure

Shares outstanding: 69.39mShares outstanding, period not labelled, at 2026-07-3169,392,766 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.